VEGFA and pulmonary arterial hypertension: BMSCs pretreated with EPO enhance pulmonary angiogenesis, promote the expression of VEGF, and attenuate vascular remodeling, thereby alleviating right ventricular hypertrophy in rats with PAH (Li et al., 2024b; Zhong et al., 2024).